Therefore, a therapeutic approach that results in the degradation of cIAPs and/or antagonism of XIAP (X-linked inhibitor of apoptosis) could promote the lethal effects of TNF on cancer cells, while shutting down the survival pathway mediated by TNF driven NF-κB expression. The gene discussed is TNF; the disease is cancer.